Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 580,176 | 628,273 | 632,138 | 617,446 | 550,676 |
| Receivables | 49,219 | 56,889 | 146,814 | 132,224 | 128,929 |
| Inventories | 47,402 | 54,819 | 43,152 | 62,424 | 60,113 |
| TOTAL | $699,312 | $765,513 | $847,902 | $835,526 | $759,382 |
| Non-Current Assets | |||||
| PPE Net | 141,619 | 87,721 | 52,694 | 48,420 | 46,956 |
| Intangibles | 561,185 | 568,147 | 500,331 | 506,434 | 512,688 |
| Other Non-Current Assets | 862,321 | 894,007 | 881,388 | 858,519 | 852,773 |
| TOTAL | $1,565,125 | $1,549,875 | $1,434,413 | $1,413,373 | $1,412,417 |
| Total Assets | $2,264,437 | $2,315,388 | $2,282,315 | $2,248,899 | $2,171,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,440 | 5,440 | 5,440 | 5,440 | 5,440 |
| Accounts payable and accrued liabilities | 6,658 | 4,784 | 5,991 | 9,459 | 23,267 |
| Accrued Expenses | 50,344 | 70,065 | 53,371 | 60,187 | 43,641 |
| TOTAL | $74,919 | $124,896 | $110,144 | $115,655 | $112,530 |
| Non-Current Liabilities | |||||
| Long Term Debt | 520,336 | 521,161 | 521,997 | 522,824 | 523,655 |
| Deferred Revenues | 2,459 | 2,053 | 3,088 | 5,822 | 5,435 |
| Other Non-Current Liabilities | 736,198 | 744,725 | 695,136 | 713,567 | 676,341 |
| TOTAL | $1,291,880 | $1,289,854 | $1,266,928 | $1,291,575 | $1,285,477 |
| Total Liabilities | $1,366,799 | $1,414,750 | $1,377,072 | $1,407,230 | $1,398,007 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 251,018 | 250,983 | 250,879 | 255,209 | 255,209 |
| Common Shares | 2,510 | 2,509 | 2,554 | 2,552 | 2,552 |
| Retained earnings | 398,158 | 404,699 | 404,766 | 367,132 | 322,663 |
| Other shareholders' equity | 377,067 | 379,121 | 360,025 | 337,908 | 317,204 |
| TOTAL | $897,638 | $900,638 | $905,243 | $841,669 | $773,792 |
| Total Liabilities And Equity | $2,264,437 | $2,315,388 | $2,282,315 | $2,248,899 | $2,171,799 |